» Articles » PMID: 39648298

Infant Feces-derived FWJL-4 Mitigates Experimental Necrotizing Enterocolitis Acetate Production

Overview
Journal Gut Microbes
Date 2024 Dec 8
PMID 39648298
Authors
Affiliations
Soon will be listed here.
Abstract

Necrotizing enterocolitis (NEC) is a life-threatening disease in premature infants, characterized by high mortality. Recent studies increasingly highlight the role of gut dysbiosis in NEC pathogenesis. Although probiotics have shown some efficacy in preventing NEC, further research is needed to determine potential strains and approaches. In this study, we demonstrated that the novel probiotic strain () FWJL-4, isolated from the feces of healthy infants, significantly enhanced intestinal barrier function, providing substantial protection against NEC. This protective effect was attributed to elevated intestinal acetate levels. Notably, acetate supplementation alone was sufficient to mitigate NEC, mimicking the protective effects of FWJL-4. Mechanistically, we revealed that FWJL-4 inhibited necroptosis and preserved the number of the goblet cells and enterocytes through the production of the short-chain fatty acid acetate, activation of the acetate receptors G protein-coupled receptor (GPR) 41 and GPR43. Our findings suggest that FWJL-4 enhances intestinal barrier function to protect against NEC, underscoring the potential of probiotic manipulation as a promising strategy for NEC prevention.

References
1.
MohanKumar K, Namachivayam K, Cheng F, Jiang R, Flores-Torres J, Torres B . Trinitrobenzene sulfonic acid-induced intestinal injury in neonatal mice activates transcriptional networks similar to those seen in human necrotizing enterocolitis. Pediatr Res. 2016; 81(1-1):99-112. PMC: 5235988. DOI: 10.1038/pr.2016.189. View

2.
MohanKumar K, Kaza N, Jagadeeswaran R, Garzon S, Bansal A, Kurundkar A . Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am J Physiol Gastrointest Liver Physiol. 2012; 303(1):G93-102. PMC: 3404576. DOI: 10.1152/ajpgi.00016.2012. View

3.
Lin P, Myers L, Ray L, Song S, Nasr T, Berardinelli A . Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med. 2009; 47(8):1205-11. PMC: 2760264. DOI: 10.1016/j.freeradbiomed.2009.07.033. View

4.
Nino D, Sodhi C, Hackam D . Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol. 2016; 13(10):590-600. PMC: 5124124. DOI: 10.1038/nrgastro.2016.119. View

5.
Ikeda T, Nishida A, Yamano M, Kimura I . Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol Ther. 2022; 239:108273. DOI: 10.1016/j.pharmthera.2022.108273. View